Complement Receptor 2 in the Regulation of the Immune Response

This publication has 75 references indexed in Scilit:

• Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2, CD21), regulates human B lymphocyte proliferation triggered through CR2
  Molecular Immunology, 1995
• Epstein‐Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways
  European Journal of Immunology, 1995
• Decreased Levels of Complement Receptor 1 (CD35) on B Lymphocytes in Persons with HIV Infection
  Clinical Immunology and Immunopathology, 1995
• Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein
  Molecular Immunology, 1995
• Erythrocyte Complement Receptors
  Critical Reviews in Immunology, 1995
• The CD19/CD21 signal transduction complex of B lymphocytes
  Immunology Today, 1994
• Expression of EBV/C3d receptors on T cells: biological significance
  Immunology Today, 1993
• The Role of Complement and Its Receptor in the Elimination of Immune Complexes
  New England Journal of Medicine, 1986
• gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes
  FEBS Letters, 1986
• Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus Erythematosus
  New England Journal of Medicine, 1979